 |
Scientific Programme
• LATE BREAKERS POSTERS, click here to view. Apr 23, 2009
• CATEGORY 1A: LIVER TRANSPLANTATION / SURGERY / ACUTE LIVER FAILURE - a. EXPERIMENTAL
• CATEGORY 2B: CIRRHOSIS AND COMPLICATIONS - b)CLINICAL ASPECTS
• CATEGORY 4A: MOLECULAR AND CELLULAR BIOLOGY - a) CELL CYCLE CONTROL / APOPTOSIS
• CATEGORY 4B: MOLECULAR AND CELLULAR BIOLOGY b) BILIARY TRACT PATHOPHYSIOLOGY
• CATEGORY 4C: MOLECULAR AND CELLULAR BIOLOGY - c) HSCs AND FIBROSIS
• CATEGORY 4E: MOLECULAR AND CELLULAR BIOLOGY e) GENE TRANSFER / GENE THERAPY
• CATEGORY 5B: VIRAL HEPATITIS - b) HEPATITIS C – EXPERIMENTAL (VIROLOGY)
• CATEGORY 5D: VIRAL HEPATITIS - d) HEPATITIS B – CLINICAL (EXCEPT THERAPY)
• CATEGORY 5F: VIRAL HEPATITIS - f) HEPATITIS C – CLINICAL (EXCEPT THERAPY)
• CATEGORY 7: PEDIATRIC HEPATOLOGY – INHERITED DISEASES OF THE LIVER
Apr 24, 2009
• CATEGORY 1B: LIVER TRANSPLANTATION / SURGERY / ACUTE LIVER FAILURE - b) CLINICAL
• CATEGORY 3A: LIVER TUMORS a) EXPERIMENTAL
• CATEGORY 5A: VIRAL HEPATITIS a) HEPATITIS B – EXPERIMENTAL
• CATEGORY 5G: VIRAL HEPATITIS - g) HEPATITIS C – CLINICAL (THERAPY)
• CATEGORY 6: AUTOIMMUNE AND CHRONIC CHOLESTATIC LIVER DISEASES
• CATEGORY 8A: ALCOHOLIC LIVER DISEASE, NAFLD AND DRUG-INDUCED LIVER DISEASE - a) EXPERIMENTAL
Apr 25, 2009
• CATEGORY 2A: CIRRHOSIS AND COMPLICATIONS - a)PATHOPHYSIOLOGY
• CATEGORY 3B: LIVER TUMORS b) CLINICAL (EPIDEMIOLOGY, DIAGNOSIS, MANAGEMENT)
• CATEGORY 4D: MOLECULAR AND CELLULAR BIOLOGY - d) LIVER REGENERATION
• CATEGORY 5C: VIRAL HEPATITIS - c) HEPATITIS C – EXPERIMENTAL (IMMUNOLOGY)
• CATEGORY 5E: VIRAL HEPATITIS - e) HEPATITIS B – CLINICAL (THERAPY, NEW COMPOUNDS, RESISTANCE)
• CATEGORY 5H: VIRAL HEPATITIS - h) HEPATITIS C – CLINICAL (NEW COMPOUNDS, RESISTANCE)
• CATEGORY 8B: ALCOHOLIC LIVER DISEASE, NAFLD AND DRUG-INDUCED LIVER DISEASE - b) CLINICAL
|